Jan Heyckendorf
Overview
Explore the profile of Jan Heyckendorf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
1252
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Neumann C, Hartung T, Boje K, Bahmer T, Keil J, Lieb W, et al.
Sci Rep
. 2025 Feb;
15(1):6833.
PMID: 40000883
Long-term changes in health-related quality of life (HrQoL) after SARS-CoV-2 infection are common, but their causes and consequences are poorly understood. This prospective, population-based study examined associations between HrQoL and...
2.
Steinborn B, Panholzer B, Heyckendorf J, Friedrichs A
Anasthesiol Intensivmed Notfallmed Schmerzther
. 2025 Feb;
60(2):78-88.
PMID: 39961307
Antibiotic stewardship (ABS) in intensive care units is confronted with challenges that go beyond a rational assessment of the use of anti-infective substances. Regular analyses of anti-infective prescribing are an...
3.
Reimann M, Avsar K, DiNardo A, Goldmann T, Gunther G, Hoelscher M, et al.
Pathog Immun
. 2025 Feb;
10(1):120-139.
PMID: 39911144
Rationale: Treatment monitoring of tuberculosis patients is complicated by a slow growth rate of . Recently, host RNA signatures have been used to monitor the response to tuberculosis treatment. Objective:...
4.
Neumann M, Reimann M, Chesov D, Popa C, Dragomir A, Popescu O, et al.
J Infect
. 2024 Dec;
90(2):106399.
PMID: 39733827
Objectives: Early detection of treatment failure is essential to improve the management of drug-resistant tuberculosis (DR-TB). We evaluated the molecular bacterial load assay (MBLA) in comparison to standard diagnostic tests...
5.
Ramachandran R, Dumitrescu A, Baiceanu D, Popa C, Dragomir A, Mahler B, et al.
J Health Popul Nutr
. 2024 Dec;
43(1):223.
PMID: 39710755
Background: Tuberculosis (TB) remains a global health challenge, with 1.3 million deaths in 2022. Ten countries in the European Union (EU) and European Economic Area (EEA) accounted for 88.3% of...
6.
Kunst H, Lange B, Hovardovska O, Bockey A, Zenner D, Andersen A, et al.
Eur Respir J
. 2024 Dec;
65(3).
PMID: 39672603
Introduction: Global migration has increased in recent decades owing to war, conflict, persecution and natural disasters, but also secondary to increased opportunities related to work or study. Migrants' risk of...
7.
Zielinski N, Baiceanu D, Dragomir A, Heyckendorf J, Ibraim E, Kohler N, et al.
Pathog Immun
. 2024 Jun;
9(2):25-42.
PMID: 38939039
Background: Neuropathic adverse events occur frequently in linezolid-containing regimens, some of which remain irreversible after drug discontinuation. Objective: We aimed to identify and validate a host RNA-based biomarker that can...
8.
Otto-Knapp R, Bauer T, Brinkmann F, Feiterna-Sperling C, Friesen I, Geerdes-Fenge H, et al.
Respiration
. 2024 May;
103(9):593-600.
PMID: 38810608
Based on the assessment of new evidence, the World Health Organization (WHO) updated its guidelines for the treatment of drug-resistant tuberculosis (TB) in December 2022. The new recommendations and the...
9.
Gillespie S, DiNardo A, Georghiou S, Sabiiti W, Kohli M, Panzner U, et al.
Lancet Microbe
. 2024 May;
5(9):100869.
PMID: 38735303
Drug development for tuberculosis is hindered by the methodological limitations in the definitions of patient outcomes, particularly the slow organism growth and difficulty in obtaining suitable and representative samples throughout...
10.
Carratala-Castro L, Ssengooba W, Kay A, Acacio S, Ehrlich J, DiNardo A, et al.
BMC Infect Dis
. 2024 Feb;
24(1):233.
PMID: 38383310
Background: Tuberculosis (TB) is a major cause of mortality worldwide. Children and people living with HIV (PLHIV) have an increased risk of mortality, particularly in the absence of rapid diagnosis....